-
Prevalence and Size-Based Risk Categorization of Pancreatic Cysts Among Asymptomatic Individuals With Screening MRI. JAMA Netw Open. 2026 Mar 02; 9(3):e260983. Wong P, Pollini T, Hernandez S, Zampese M, Todeschini L, Aguilar LL, Basar SA, Hashemi S, Maker AV. PMID: 41801199; PMCID: PMC12973103.
-
Current Management of Intraductal Papillary Mucinous Neoplasms. Hematol Oncol Clin North Am. 2026 Feb; 40(1):65-77. Pollini T, Wong P, Maker AV. PMID: 41224443.
-
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee. J Immunother Cancer. 2025 Nov 29; 13(11). Coukos G, Donia M, Gastman BR, Goff SL, Gros A, Harari A, Hernandez S, Ito F, Maker AV, Mullinax JE, Murthy P, Pai SI, Prabhakaran S, Restifo NP, Silver NL, Marincola Smith P, Turcotte S, Wagner PL, Yang JC, Lotze MT. PMID: 41320228.
-
Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases. Sci Adv. 2025 Oct 10; 11(41):eadv9161. Keenan BP, Qiao G, Kunda N, Kone L, Guldberg SM, Todeschini L, Kumar P, Pollini T, Hernandez S, Qin J, Fong L, Spitzer MH, Prabhakar BS, Maker AV. PMID: 41061056; PMCID: PMC12506966.
-
Minimally Invasive Distal Pancreatectomy as the Standard of Care in the US: Are We There Yet? Cancers (Basel). 2025 Sep 16; 17(18). Foroutani L, Gonzalez A, Wang JJ, Aburayya BI, Ganjouei AA, Feng J, Thornblade LW, Hirose K, Maker AV, Nakakura E, Corvera CU, Alseidi A, Adam MA. PMID: 41008859; PMCID: PMC12468204.
-
Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression. Cancer Cell. 2025 Nov 10; 43(11):2156-2170.e6. Wang Y, Lih TM, Lee JW, Ohtsuka T, Hozaka Y, Mino-Kenudson M, Adsay NV, Luchini C, Scarpa A, Maker AV, Kim GE, Paulino J, Chen L, Woo J, Jiao L, Sun Z, Goodman D, Pflüger MJ, Roberts NJ, Matthaei H, Goggins MG, Wood LD, Furukawa T, Zhang H, Hruban RH. PMID: 40882635; PMCID: PMC12482137.
-
The morbidity of simultaneous pancreatic and liver resection for metastatic pancreatic neuroendocrine tumors. J Gastrointest Surg. 2025 10; 29(10):102163. Kone LB, Wong P, Jacobs MJ, Maker AV. PMID: 40738420.
-
Minimally Invasive Versus Open Resection for Solid Pseudopapillary Tumors of the Pancreas: A Propensity Score-Matched Analysis. J Surg Oncol. 2025 Sep; 132(4):676-683. Wong P, Todeschini L, Pollini T, Hernandez S, Zampese M, Aguilar LL, Peng JS, Thornblade LW, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Maker AV. PMID: 40716080.
-
San Francisco Is Not Sendai-When Do We Stop Surveillance of Pancreatic Cysts? Ann Surg. 2026 Feb 01; 283(2):193-194. Maker AV. PMID: 40626602.
-
Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across a decade. HPB (Oxford). 2025 Sep; 27(9):1223-1235. Wong P, Lewis A, Thornblade LW, Maker AV, Fong Y, Melstrom LG. PMID: 40640040.
-
Novel Computational Analysis Identifies Cytotoxic Lymphocyte-to-Monocyte Balance in Tumors as a Predictor of Recurrence-Free Survival in Colorectal Carcinoma. Ann Surg Oncol. 2025 Sep; 32(9):6980-6990. Fernandez M, Todeschini L, Keenan BP, Rosenberg D, Hernandez S, Zampese M, Qiao G, Pollini T, Maker AV. PMID: 40544207; PMCID: PMC12260141.
-
ASO Author Reflections: Precision Immunoprofiling of the Tumor Microenvironment Predicts Recurrence in Advanced Colorectal Cancer. Ann Surg Oncol. 2025 Sep; 32(9):7082-7083. Todeschini L, Hernandez S, Maker AV. PMID: 40526346; PMCID: PMC12602063.
-
Impact of coronary artery stenting on perioperative mortality and complications in patients undergoing pancreaticoduodenectomy. J Gastrointest Surg. 2025 05; 29(5):102020. Wong P, Tran TB, Pollini T, Hernandez S, Zampese M, Todeschini L, Aguilar LL, Maker VK, Maker AV. PMID: 40118202.
-
Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent: Erratum. Ann Surg. 2025 04 01; 281(4):e5. Kone LB, Perez-Iglesias CT, Banulescu M, Maker VK, Maker AV. PMID: 40073038.
-
Delayed Gastric Emptying After Whipple: Pyloric Manipulation Will Not Solve It, but the Body Compensates. Ann Surg Oncol. 2025 Jun; 32(6):3861-3862. Maker AV. PMID: 40048029.
-
Launch of the PANC-PALS Consortium. Lancet Gastroenterol Hepatol. 2024 Dec; 9(12):1084-1085. Javed AA, Hidalgo Salinas C, Wolfgang CL, Besselink MG, PANC-PALS Consortium. PMID: 39520999.
-
Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery: An HPB/CGSO Training Program Survey. Ann Surg Oncol. 2025 Jan; 32(1):382-390. Kone LB, Seok D, Kimble MM, Maker AV, Patil S, Mittal V, Jacobs M. PMID: 39349910.
-
Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC). Curr Oncol. 2024 08 28; 31(9):5008-5020. Yin H, Romero-Hernandez F, Ganjouei AA, Wang JJ, Brown A, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Wilhelm A, Peng JS, Alseidi A, Adam MA. PMID: 39329998; PMCID: PMC11430823.
-
Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients. J Gastrointest Surg. 2024 Nov; 28(11):1799-1804. Hoffman D, Ganjouei AA, Hernandez FR, Ifuku K, Miller P, Glencer A, Corvera C, Kirkwood K, Alseidi A, Adam M, Maker A, Hirose K, Hirose R, Nakakura EK. PMID: 39181231.
-
ASO Author Reflections: Is Adjuvant Therapy Necessary for All Patients with Invasive Mucinous Cystic Neoplasms of the Pancreas? Let's De-escalate. Ann Surg Oncol. 2024 Nov; 31(12):8352-8353. Wong P, Pollini T, Maker AV. PMID: 39080135.
-
ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer. Ann Surg Oncol. 2024 Jul 27. Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK. PMID: 39068310.
-
Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression. bioRxiv. 2024 Jul 07. Wang Y, Lih TM, Lee JW, Ohtsuka T, Hozaka Y, Mino-Kenudson M, Adsay NV, Luchini C, Scarpa A, Maker AV, Kim GE, Paulino J, Chen L, Jiao L, Sun Z, Goodman D, Pflüger MJ, Roberts NJ, Matthaei H, Wood LD, Furukawa T, Zhang H, Hruban RH. PMID: 39005476; PMCID: PMC11245086.
-
The impact of the California state lockdown during the COVID-19 pandemic on management of patients with pancreatic ductal adenocarcinoma. J Surg Oncol. 2024 Aug; 130(2):276-283. Oviedo P, Burns S, Chen WP, Mandl HK, Rosso C, Radgoudarzi N, Crosetti A, Zamora S, Perry LM, Bold RJ, Labora AN, Donahue TR, Maker A, Valerin JB, Zell JA, White RR. PMID: 38894577; PMCID: PMC11323303.
-
Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer. Ann Surg Oncol. 2024 Sep; 31(9):6147-6156. Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK. PMID: 38879670; PMCID: PMC11300478.
-
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guidelines. Hepatobiliary Surg Nutr. 2024 Jun 01; 13(3):516-519. Maker AV. PMID: 38911219; PMCID: PMC11190518.
-
Pancreas Cyst Diagnosis and Advances in Cyst Fluid Analysis. Surg Clin North Am. 2024 Oct; 104(5):965-974. Pollini T, Todeschini L, Maker AV. PMID: 39237171.
-
Intraoperative hepatic artery infusion pump perfusion testing with indocyanine green near-infrared imaging offers multiple potential advantages. J Gastrointest Surg. 2024 Apr; 28(4):598-599. Wong P, Hoffman D, Pollini T, Zampese M, Corvera CU, Maker AV. PMID: 38583918.
-
"Mickey Mouse sign" to identify and remove cystic duct stones in postcholecystectomy syndrome. J Gastrointest Surg. 2024 Mar; 28(3):334-335. O'Rear J, Wong P, Pollini T, Maker VK, Maker AV. PMID: 38445928.
-
Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases. J Gastrointest Surg. 2024 Mar; 28(3):246-251. Pollini T, Tran T, Wong P, Adam MA, Alseidi A, Corvera C, Hirose K, Nakakura E, Warren R, Maker VK, Maker AV. PMID: 38445916; PMCID: PMC12279386.
-
Educating Cancer-Associated Fibroblasts (CAFs): Are They the Student or the Teacher? Ann Surg Oncol. 2024 Apr; 31(4):2181-2182. Maker AV, Karakousis G. PMID: 38180705.
-
Surgical Cancer Care in Safety-Net Hospitals: a Systematic Review. J Gastrointest Surg. 2023 12; 27(12):2920-2930. Wong P, Victorino GP, Sadjadi J, Knopf K, Maker AV, Thornblade LW. PMID: 37968551.
-
Impact of safety-net hospital burden on achievement of textbook oncologic outcomes following resection in for stage I-IV colorectal cancer. J Surg Oncol. 2024 Feb; 129(2):284-296. Wong P, Victorino GP, Miraflor E, Alseidi A, Maker AV, Thornblade LW. PMID: 37815003.
-
Concomitant Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm in Pancreatic Cysts-a Diagnostic and Surgical Dilemma. J Gastrointest Surg. 2023 12; 27(12):3105-3107. Pollini T, Salvia R, Maker AV. PMID: 37783910.
-
A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data. Ann Surg Oncol. 2023 Nov; 30(12):7738-7747. Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA. PMID: 37550449.
-
ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival. Ann Surg Oncol. 2023 Aug; 30(8):5131. Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA. PMID: 37221399.
-
Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance. Cancers (Basel). 2023 May 31; 15(11). Wiley MB, Bauer J, Mehrotra K, Zessner-Spitzenberg J, Kolics Z, Cheng W, Castellanos K, Nash MG, Gui X, Kone L, Maker AV, Qiao G, Reddi D, Church DN, Kerr RS, Kerr DJ, Grippo PJ, Jung B. PMID: 37296966; PMCID: PMC10252122.
-
National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival. Ann Surg Oncol. 2023 Aug; 30(8):5119-5129. Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA. PMID: 37140748.
-
It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy. HPB (Oxford). 2023 07; 25(7):747-757. Pollini T, Marchegiani G, Facciorusso A, Balduzzi A, Biancotto M, Bassi C, Maker AV, Salvia R. PMID: 37003852.
-
Drain Placement After Pancreatic Resection: Friend or Foe For Surgical Site Infections? J Gastrointest Surg. 2023 04; 27(4):724-729. Pollini T, Wong P, Kone LB, Khoury RE, Kabir C, Maker VK, Banulescu M, Maker AV. PMID: 36737592.
-
Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy. J Gastrointest Surg. 2023 02; 27(2):328-336. Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA. PMID: 36624324.
-
The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection. Ann Surg Oncol. 2023 Mar; 30(3):1453-1462. Pollini T, Wong P, Maker AV. PMID: 36600097; PMCID: PMC9908620.
-
Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States. Cancers (Basel). 2022 Dec 30; 15(1). Calthorpe L, Romero-Hernandez F, Miller P, Conroy PC, Hirose K, Kim A, Kirkwood K, Nakakura E, Corvera C, Maker AV, Alseidi A, Adam MA. PMID: 36612225; PMCID: PMC9818958.
-
Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand? World J Surg. 2023 03; 47(3):750-758. Miller PN, Romero-Hernandez F, Conroy P, Calthorpe L, Yilma M, Mohamedaly S, Kelly YM, Feng J, Hirose K, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA. PMID: 36402918.
-
Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery. Cancers (Basel). 2022 Nov 16; 14(22). Romero-Hernandez F, Mohamedaly S, Miller P, Rodriguez N, Calthorpe L, Conroy PC, Ganjouei AA, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Alseidi A, Adam MA. PMID: 36428717; PMCID: PMC9688336.
-
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms. Lancet Gastroenterol Hepatol. 2022 12; 7(12):1141-1150. Pollini T, Adsay V, Capurso G, Dal Molin M, Esposito I, Hruban R, Luchini C, Maggino L, Matthaei H, Marchegiani G, Scarpa A, Wood LD, Bassi C, Salvia R, Mino-Kenudson M, Maker AV. PMID: 36057265; PMCID: PMC9844533.
-
Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis. J Surg Oncol. 2022 Sep; 126(4):649-657. Leder Macek AJ, Wang A, Turgeon MK, Lee RM, Russell MC, Porembka MR, Alterio R, Ju M, Kronenfeld J, Goel N, Datta J, Maker AV, Fernandez M, Richter H, Berman RS, Correa-Gallego C, Lee AY. PMID: 35699351; PMCID: PMC10029827.
-
Physical exam reveals etiology of liver and pancreatic tumors. Surgery. 2022 10; 172(4):e43-e44. Kone LB, Maker AV. PMID: 35659784.
-
Langer's arch: An anatomic variant complicating axillary node dissection. Surgery. 2022 08; 172(2):e19-e20. Baskin AS, Wang K, Maker AV. PMID: 35260249.
-
Robotic Surgery for Biliary Tract Cancer. Cancers (Basel). 2022 Feb 18; 14(4). Kone LB, Bystrom PV, Maker AV. PMID: 35205792; PMCID: PMC8869869.
-
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer. Oncogene. 2022 04; 41(14):2054-2068. Qiao G, Kone LB, Phillips EH, Lee SS, Brown GE, Khetani SR, Thakur A, Lum LG, Prabhakar BS, Maker AV. PMID: 35177811; PMCID: PMC8975745.
-
Clinical Presentation Patterns and Survival Outcomes of Hispanic Patients With Gastric Cancer. J Surg Res. 2021 12; 268:606-615. Vitiello GA, Hani L, Wang A, Porembka MR, Alterio R, Ju M, Turgeon MK, Lee RM, Russell MC, Kronenfeld J, Goel N, Datta J, Maker AV, Fernandez M, Richter H, Correa-Gallego C, Berman RS, Lee AY. PMID: 34469859; PMCID: PMC8678299.
-
Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis. J Surg Oncol. 2021 Dec; 124(8):1317-1328. Kronenfeld JP, Collier AL, Turgeon MK, Ju M, Alterio R, Wang A, Fernandez M, Porembka MR, Richter H, Lee AY, Russell MC, Merchant NB, Maker AV, Datta J. PMID: 34379324; PMCID: PMC8595640.
-
The Evolution of Cancer Immunotherapy. Vaccines (Basel). 2021 Jun 08; 9(6). Khan M, Maker AV, Jain S. PMID: 34200997; PMCID: PMC8227172.
-
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers? J Surg Oncol. 2021 Sep; 124(4):551-559. Turgeon MK, Lee RM, Keilson JM, Ju MR, Porembka MR, Alterio RE, Kronenfeld J, Datta J, Goel N, Wang A, Lee AY, Fernandez M, Richter H, Maker AV, Maithel SK, Russell MC. PMID: 34061369; PMCID: PMC8394621.
-
Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban Setting. J Cancer Educ. 2021 06; 36(3):567-575. Carnahan LR, Jones L, Brewer KC, Watts EA, Peterson CE, Ferrans CE, Cipriano-Steffens T, Polite B, Maker AV, Chowdhery R, Molina Y, Rauscher GH. PMID: 31838729; PMCID: PMC7293559.
-
Combining On-Table Embolization with Immediate Resection to Safely Excise Giant Hepatic Hemangiomas. J Gastrointest Surg. 2021 06; 25(6):1651-1653. Maker AV, Al Rameni D, Prabhakar N. PMID: 33634420; PMCID: PMC8206027.
-
Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo. J Surg Res. 2021 07; 263:44-52. Fernandez MF, Qiao G, Tulla K, Prabhakar BS, Maker AV. PMID: 33631377; PMCID: PMC8169541.
-
ASO Author Reflections: How Can We Improve the Postoperative Experience for Our Pancreatic Cancer Patients? A Practical Technique to Optimize Pain Control After Major Abdominal Surgery. Ann Surg Oncol. 2021 Apr; 28(4):2296-2298. Maker AV. PMID: 32914388; PMCID: PMC7940497.
-
Surgeon-Placed Continuous Wound Infusion Pain Catheters Markedly Decrease Narcotic Use and Improve Outcomes After Pancreatic Tumor Resection. Ann Surg Oncol. 2021 Apr; 28(4):2287-2295. Kone LB, Kunda NM, Tran TB, Maker AV. PMID: 32880771.
-
Epidural Analgesia Is Associated with Prolonged Length of Stay After Open HPB Surgery in Over 27,000 Patients. J Gastrointest Surg. 2021 07; 25(7):1716-1726. Kone LB, Maker VK, Banulescu M, Maker AV. PMID: 32725519.
-
Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent. Ann Surg. 2022 06 01; 275(6):1175-1183. Kone LB, Torres C, Banulescu M, Maker VK, Maker AV. PMID: 32740256.
-
Should Drains Suck? A Propensity Score Analysis of Closed-Suction Versus Closed-Gravity Drainage After Pancreatectomy. J Gastrointest Surg. 2021 05; 25(5):1224-1232. Kone LB, Maker VK, Banulescu M, Maker AV. PMID: 32394123.
-
Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice. Cancer Gene Ther. 2020 12; 27(12):923-933. Dai S, Lv Y, Xu W, Yang Y, Liu C, Dong X, Zhang H, Prabhakar BS, Maker AV, Seth P, Wang H. PMID: 32307442.
-
Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations. Ann Surg Oncol. 2020 Jun; 27(6):1717-1720. Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, Levine E, Maker A, Mamounas E, McGuire K, Merchant N, Shibata D, Sohn V, Solorzano C, Turaga K, White R, Yang A, Yoon S, Society of Surgical Oncology. PMID: 32270420; PMCID: PMC7141488.
-
A propensity score analysis of over 12,000 pancreaticojejunal anastomoses after pancreaticoduodenectomy: does technique impact the clinically relevant fistula rate? HPB (Oxford). 2020 10; 22(10):1394-1401. Kone LB, Maker VK, Banulescu M, Maker AV. PMID: 32019740.
-
MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer. Endocr Relat Cancer. 2019 06 01; 26(6):551-563. Saini S, Sripada L, Tulla K, Qiao G, Kunda N, Maker AV, Prabhakar BS. PMID: 30999276.
-
Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential. J Am Coll Surg. 2019 05; 228(5):721-729. Maker AV, Hu V, Kadkol SS, Hong L, Brugge W, Winter J, Yeo CJ, Hackert T, Büchler M, Lawlor RT, Salvia R, Scarpa A, Bassi C, Green S. PMID: 30794864; PMCID: PMC6487216.
-
Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer. Cell Death Dis. 2019 02 13; 10(2):145. Saini S, Sripada L, Tulla K, Kumar P, Yue F, Kunda N, Maker AV, Prabhakar BS. PMID: 30760700; PMCID: PMC6374448.
-
Impact of Immunotherapy after Resection of Pancreatic Cancer. J Am Coll Surg. 2019 07; 229(1):19-27.e1. Tran TB, Maker VK, Maker AV. PMID: 30742911; PMCID: PMC6599571.
-
Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer. Biochim Biophys Acta Rev Cancer. 2019 12; 1872(2):188262. Saini S, Maker AV, Burman KD, Prabhakar BS. PMID: 30605717.
-
Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association. HPB (Oxford). 2019 05; 21(5):515-523. Mansour JC, Chavin K, Morris-Stiff G, Warner SG, Cardona K, Fong ZV, Maker A, Libutti SK, Warren R, St Hill C, Celinski S, Newell P, Ly QP, Howe J, Coburn N. PMID: 30527517.
-
Does attending a Delphi consensus conference impact surgeon attitudes? Survey results from the Americas HepatoPancreatoBiliary Association consensus conference on small asymptomatic pancreatic neuroendocrine tumors. HPB (Oxford). 2019 05; 21(5):524-530. Maker AV, Tran TB, Coburn N, Fong ZV, Cardona K, Newell P, Morris-Stiff G, Chavin K, Mansour J, members of the AHPBA Research Committee Consensus Conference. PMID: 30442562.
-
Therapeutic advances in anaplastic thyroid cancer: a current perspective. Mol Cancer. 2018 10 23; 17(1):154. Saini S, Tulla K, Maker AV, Burman KD, Prabhakar BS. PMID: 30352606; PMCID: PMC6198524.
-
ASO Author Reflections: Improving Identification of Intraductal Papillary Mucinous Neoplasm Patients at Risk-Current Status and the Role of IPMN Molecular Biomarkers. Ann Surg Oncol. 2018 12; 25(Suppl 3):818-819. Maker AV. PMID: 30311163; PMCID: PMC6333491.
-
Identification of a Novel OX40L+ Dendritic Cell Subset That Selectively Expands Regulatory T cells. Sci Rep. 2018 10 08; 8(1):14940. Marinelarena A, Bhattacharya P, Kumar P, Maker AV, Prabhakar BS. PMID: 30297856; PMCID: PMC6175872.
-
KRASG12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs. Sci Rep. 2018 08 22; 8(1):12548. Principe DR, Overgaard NH, Park AJ, Diaz AM, Torres C, McKinney R, Dorman MJ, Castellanos K, Schwind R, Dawson DW, Rana A, Maker A, Munshi HG, Rund LA, Grippo PJ, Schook LB. PMID: 30135483; PMCID: PMC6105629.
-
Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases. J Surg Res. 2019 01; 233:57-64. Qin J, Kunda NM, Qiao G, Tulla K, Prabhakar BS, Maker AV. PMID: 30502288.
-
Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation. Cell Mol Immunol. 2019 02; 16(2):138-153. Kumar P, Marinelarena A, Raghunathan D, Ragothaman VK, Saini S, Bhattacharya P, Fan J, Epstein AL, Maker AV, Prabhakar BS. PMID: 29578532; PMCID: PMC6355936.
-
What is the Incidence of Malignancy in Resected Intraductal Papillary Mucinous Neoplasms? An Analysis of Over 100 US Institutions in a Single Year. Ann Surg Oncol. 2018 Jun; 25(6):1746-1751. Khoury RE, Kabir C, Maker VK, Banulescu M, Wasserman M, Maker AV. PMID: 29560572.
-
Do Drains Contribute to Pancreatic Fistulae? Analysis of over 5000 Pancreatectomy Patients. J Gastrointest Surg. 2018 06; 22(6):1007-1015. El Khoury R, Kabir C, Maker VK, Banulescu M, Wasserman M, Maker AV. PMID: 29435899.
-
Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas. Langenbecks Arch Surg. 2018 Mar; 403(2):151-194. Tulla KA, Maker AV. PMID: 29218397.
-
Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply. Ann Surg Oncol. 2017 12; 24(Suppl 3):647-648. Maker AV, Jarnagin WR. PMID: 29116487.
-
Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study. Ann Epidemiol. 2017 11; 27(11):731-738.e1. Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA, Rauscher GH. PMID: 29173578; PMCID: PMC5728690.
-
The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform. Front Oncol. 2017; 7:190. Schachtschneider KM, Schwind RM, Newson J, Kinachtchouk N, Rizko M, Mendoza-Elias N, Grippo P, Principe DR, Park A, Overgaard NH, Jungersen G, Garcia KD, Maker AV, Rund LA, Ozer H, Gaba RC, Schook LB. PMID: 28879168; PMCID: PMC5572387.
-
PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells. Sci Rep. 2017 07 26; 7(1):6594. Alharshawi K, Marinelarena A, Kumar P, El-Sayed O, Bhattacharya P, Sun Z, Epstein AL, Maker AV, Prabhakar BS. PMID: 28747670; PMCID: PMC5529425.
-
Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia. Langenbecks Arch Surg. 2017 Sep; 402(6):873-883. Maker AV, Sheikh R, Bhagia V, Diabetes Control and Complications Trial (DCCT) Research Group. PMID: 28733926.
-
A Technique to Define Extrahepatic Biliary Anatomy Using Robotic Near-Infrared Fluorescent Cholangiography. J Gastrointest Surg. 2017 Nov; 21(11):1961-1962. Maker AV, Kunda N. PMID: 28585107.
-
Targeting cancer with tumor-specific therapeutic strategies-metabolic reprogramming beyond the Warburg effect. Transl Cancer Res. 2017 May; 6(Suppl 3):S585-S586. Grippo P, Maker AV. PMID: 28868241; PMCID: PMC5578475.
-
Mitochondrial protein 18 (MTP18) plays a pro-apoptotic role in chemotherapy-induced gastric cancer cell apoptosis. Oncotarget. 2017 Aug 22; 8(34):56582-56597. Aung LHH, Li R, Prabhakar BS, Maker AV, Li P. PMID: 28915614; PMCID: PMC5593585.
-
Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis. J Surg Res. 2017 07; 215:12-20. Ejaz A, Casadaban L, Maker AV. PMID: 28688636; PMCID: PMC5604846.
-
LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases. Cancer Res. 2017 04 15; 77(8):1880-1891. Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV. PMID: 28249900; PMCID: PMC5410174.
-
Isolated Pancreatic Uncinate Duct IPMN. J Gastrointest Surg. 2017 04; 21(4):744-745. Maker AV, Maker VK. PMID: 28205123.
-
Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death. Cell Death Dis. 2017 02 02; 8(2):e2584. Qin J, Kunda N, Qiao G, Calata JF, Pardiwala K, Prabhakar BS, Maker AV. PMID: 28151483; PMCID: PMC5386459.
-
Can Colon Cancer Recurrence and Metastases Be Determined After Surgical Resection Using a Gene Expression Signature? J Clin Oncol. 2017 04 20; 35(12):1372-1373. Casadaban L, Maker AV. PMID: 28113016.
-
Gene-expression profiling to predict responsiveness to immunotherapy. Cancer Gene Ther. 2017 Mar; 24(3):134-140. Jamieson NB, Maker AV. PMID: 27834354; PMCID: PMC5386795.
-
Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis. Cell Death Discov. 2016; 2:16067. Carr RM, Qiao G, Qin J, Jayaraman S, Prabhakar BS, Maker AV. PMID: 27648301; PMCID: PMC5018545.
-
Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. Cancer. 2016 Nov 15; 122(21):3277-3287. Casadaban L, Rauscher G, Aklilu M, Villenes D, Freels S, Maker AV. PMID: 27417445; PMCID: PMC5073024.
-
Techniques to perform robotic left adrenalectomy in the obese patient. Surg Endosc. 2017 02; 31(2):950. Maker AV, Maker VK. PMID: 27387175; PMCID: PMC5219870.
-
Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis. J Gastrointest Surg. 2016 Apr; 20(4):869-70. Maker AV, August C, Maker VK, Weisenberg E. PMID: 26847353; PMCID: PMC4803592.
-
A Minimally Invasive Technique to Obtain Optimal Tumor Margins in Anatomically Confined Locations Using a Contoured Stapler. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S340. Maker AV, Valbuena V, Maker VK. PMID: 26265368.
-
Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment-Evidence to turn on the LIGHT. Oncoimmunology. 2016; 5(1):e1069937. Maker AV. PMID: 26942091; PMCID: PMC4760328.
-
The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses. J Clin Cell Immunol. 2015 Aug; 6(4). Maker AV, Prabhakar B, Pardiwala K. PMID: 26618054; PMCID: PMC4662376.
-
Techniques to perform a laparoscopic right adrenalectomy for metastases abutting the liver, renal vein, and posterior vena cava. Surg Endosc. 2016 Mar; 30(3):1226. Maker AV, Carr R. PMID: 26139482; PMCID: PMC4698360.
-
Symptomatic Massive Splenomegaly in Persistent Polyclonal B-cell Lymphocytosis Requiring Splenectomy. Open J Clin Med Case Rep. 2015; 1(3). Bhagwandin SB, Weisenberg ES, Ozer H, Maker AV. PMID: 26693179; PMCID: PMC4675630.
-
Tailoring GIST therapy—biology is still king. JAMA Surg. 2015 Apr; 150(4):306-7. Maker AV. PMID: 25671489.
-
Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. J Hepatol. 2015 Aug; 63(2):429-36. Kopanja D, Pandey A, Kiefer M, Wang Z, Chandan N, Carr JR, Franks R, Yu DY, Guzman G, Maker A, Raychaudhuri P. PMID: 25828473; PMCID: PMC4508215.
-
Simultaneous Occurrence of Glandular and Neuroendocrine Components in Lymph Node Metastasis of Gastric MANEC. Int J Surg Pathol. 2015 Aug; 23(5):375-6. August C, Maker AV, Weisenberg E. PMID: 25807951.
-
Closure of Melanoma Defects on the Sole of the Foot Using Glaborous Skin: The End of the Flap? Ann Surg Oncol. 2015 Nov; 22(12):4081-2. Maker AV, Iteld L. PMID: 25749930.
-
Operative management of portal annular pancreas during pancreaticoduodenectomy. Surgery. 2016 Mar; 159(3):972-4. Pardiwala KH, Maker AV. PMID: 26144878.
-
Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunol Res. 2015 Apr; 3(4):380-8. Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI. PMID: 25600439; PMCID: PMC4390462.
-
Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms. J Am Coll Surg. 2015 Feb; 220(2):243-53. Maker AV, Carrara S, Jamieson NB, Pelaez-Luna M, Lennon AM, Dal Molin M, Scarpa A, Frulloni L, Brugge WR. PMID: 25592469; PMCID: PMC4304635.
-
Appendicitis secondary to metastatic melanoma: review of the National Institutes of Health experience. JAMA Surg. 2014 Jul; 149(7):735-8. Kitano M, Maker AV, Lanier BJ, Danforth DN, Kammula US. PMID: 24871401.
-
Calcifying fibrous tumor of the small intestine associated with Castleman-like lymphadenopathy. J Gastrointest Surg. 2014 Jun; 18(6):1205-8. Valladolid G, Weisenberg E, Sundaresan R, Maker AV. PMID: 24452381.
-
Dedifferentiated gastrointestinal stromal tumor arising de novo from the small intestine. Pathol Res Pract. 2014 Apr; 210(4):264-6. Choi JJ, Sinada-Bottros L, Maker AV, Weisenberg E. PMID: 24484970.
-
IG20/MADD plays a critical role in glucose-induced insulin secretion. Diabetes. 2014 May; 63(5):1612-23. Li LC, Wang Y, Carr R, Haddad CS, Li Z, Qian L, Oberholzer J, Maker AV, Wang Q, Prabhakar BS. PMID: 24379354; PMCID: PMC3994957.
-
Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. PLoS One. 2013; 8(12):e81680. Ito H, Mo Q, Qin LX, Viale A, Maithel SK, Maker AV, Shia J, Kingham P, Allen P, DeMatteo RP, Fong Y, Jarnagin WR, D'Angelica M. PMID: 24339954; PMCID: PMC3858250.
-
Benign adrenal hemangiomas may mimic metastases on PET. Clin Nucl Med. 2013 Nov; 38(11):888-90. Calata JF, Sukerkar AN, August CZ, Maker AV. PMID: 24089061.
-
Management of patients with abdominal malignancy after remote jejunoileal bypass: surgical considerations decades later. J Am Coll Surg. 2013 Nov; 217(5):929-39. Kaminski JP, Maker VK, Maker AV. PMID: 24021299.
-
A technique for laparoendoscopic resection of posterior fundic gastric GISTs without need for a gastrotomy. Ann Surg Oncol. 2013 Dec; 20(13):4238. Maker AV. PMID: 23943037.
-
Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes. J Surg Oncol. 2013 Jul; 108(1):57-62. Avraham JB, Villines D, Maker VK, August C, Maker AV. PMID: 23677677.
-
Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases. J Transl Med. 2013 Mar 20; 11:70. Qin JZ, Upadhyay V, Prabhakar B, Maker AV. PMID: 23514280; PMCID: PMC3623860.
-
MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells. PLoS One. 2013; 8(2):e56817. Turner A, Li LC, Pilli T, Qian L, Wiley EL, Setty S, Christov K, Ganesh L, Maker AV, Li P, Kanteti P, Das Gupta TK, Prabhakar BS. PMID: 23457619; PMCID: PMC3574069.
-
Primary hepatic lymphoma presenting as an isolated solitary hepatic cyst. J Clin Oncol. 2013 Jan 10; 31(2):e21-3. Valladolid G, Adams LL, Weisenberg E, Maker VK, Maker AV. PMID: 23169506.
-
Can we predict which residents are going to pass/fail the oral boards? J Surg Educ. 2012 Nov-Dec; 69(6):705-13. Maker VK, Zahedi MM, Villines D, Maker AV. PMID: 23111034.
-
Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol. 2013 Mar; 20(3):946-55. Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, DeMatteo RP. PMID: 23010736; PMCID: PMC3740360.
-
Malignant masquerade of xanthogranulomatous cholecystitis on intraoperative ultrasound of the liver. J Surg Oncol. 2012 Sep 15; 106(4):525-6. Maker AV, Maker VK. PMID: 22410841.
-
Video: totally laparoscopic left lateral segmentectomy for hepatic malignancies: a modified technique. J Gastrointest Surg. 2011 Sep; 15(9):1650. Maker AV, Jamal W, Gayet B. PMID: 21630104.
-
Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol. 2012 Feb; 19(2):409-17. Maker AV, Butte JM, Oxenberg J, Kuk D, Gonen M, Fong Y, Dematteo RP, D'Angelica MI, Allen PJ, Jarnagin WR. PMID: 21698501.
-
Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells. Am J Obstet Gynecol. 2011 Oct; 205(4):362.e12-25. Li LC, Jayaram S, Ganesh L, Qian L, Rotmensch J, Maker AV, Prabhakar BS. PMID: 21855847; PMCID: PMC3217125.
-
Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2011 Mar 15; 17(6):1502-8. Maker AV, Katabi N, Qin LX, Klimstra DS, Schattner M, Brennan MF, Jarnagin WR, Allen PJ. PMID: 21266527; PMCID: PMC3065716.
-
Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol. 2011 Jan; 18(1):199-206. Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ. PMID: 20717734; PMCID: PMC4241376.
-
Randomized clinical trials in pancreatic adenocarcinoma. Surg Oncol Clin N Am. 2010 Jan; 19(1):115-50. Rudloff U, Maker AV, Brennan MF, Allen PJ. PMID: 19914563.
-
Novel presentation of a familial pancreatic cancer syndrome. J Gastrointest Surg. 2009 Jun; 13(6):1151-4. Maker AV, Warth JA, Zinner MJ. PMID: 19089513.
-
Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol. 2008 Nov; 15(11):3187-92. Maker AV, Lee LS, Raut CP, Clancy TE, Swanson RS. PMID: 18766406.
-
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J Immunother. 2006 Jul-Aug; 29(4):455-63. Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SA. PMID: 16799341; PMCID: PMC2134804.
-
Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. J Immunother. 2006 Mar-Apr; 29(2):208-14. Attia P, Powell DJ, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA. PMID: 16531821; PMCID: PMC1473974.
-
Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J Immunol. 2005 Dec 01; 175(11):7746-54. Maker AV, Attia P, Rosenberg SA. PMID: 16301685; PMCID: PMC1473972.
-
Images in cardiothoracic surgery. Active malignant pleural effusion captured through the thoracoscope. Ann Thorac Surg. 2005 Nov; 80(5):1941. Maker AV, Nguyen DM. PMID: 16242497.
-
Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J Immunother. 2005 Nov-Dec; 28(6):582-92. Attia P, Maker AV, Haworth LR, Rogers-Freezer L, Rosenberg SA. PMID: 16224276; PMCID: PMC1533764.
-
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol. 2005 Dec; 12(12):1005-16. Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA. PMID: 16283570; PMCID: PMC1473970.
-
Loss of S100 antigenicity in metastatic melanoma. Hum Pathol. 2005 Sep; 36(9):1016-9. Aisner DL, Maker A, Rosenberg SA, Berman DM. PMID: 16153466; PMCID: PMC2656365.
-
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol. 2005 Sep 01; 23(25):6043-53. Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA. PMID: 16087944; PMCID: PMC1473965.
-
Rapid acute amiodarone-induced hepatotoxicity in a burn patient. J Burn Care Rehabil. 2005 Jul-Aug; 26(4):341-3. Maker AV, Orgill DP. PMID: 16006841.
-
Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane. Cell Physiol Biochem. 2005; 15(1-4):51-8. Eisenberg ML, Maker AV, Slezak LA, Nathan JD, Sritharan KC, Jena BP, Geibel JP, Andersen DK. PMID: 15665515.
US